Advisor Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $14K | Sell |
345
-1,159
| -77% | -$47K | ﹤0.01% | 4137 |
|
|
2019
Q3 | $65K | Buy |
1,504
+1,123
| +295% | +$48.5K | ﹤0.01% | 3194 |
|
|
2019
Q2 | $24K | Sell |
381
-10
| -3% | -$630 | ﹤0.01% | 3861 |
|
|
2019
Q1 | $27K | Buy |
391
+87
| +29% | +$6.01K | ﹤0.01% | 3800 |
|
|
2018
Q4 | $13K | Buy |
304
+39
| +15% | +$1.67K | ﹤0.01% | 4059 |
|
|
2018
Q3 | $20K | Buy |
265
+182
| +219% | +$13.7K | ﹤0.01% | 3901 |
|
|
2018
Q2 | $6K | Sell |
83
-1
| -1% | -$72 | ﹤0.01% | 4309 |
|
|
2018
Q1 | $4K | Sell |
84
-5
| -6% | -$238 | ﹤0.01% | 4497 |
|
|
2017
Q4 | $4K | Buy |
89
+40
| +82% | +$1.8K | ﹤0.01% | 4500 |
|
|
2017
Q3 | $3K | Sell |
49
-83
| -63% | -$5.08K | ﹤0.01% | 4431 |
|
|
2017
Q2 | $8K | Sell |
132
-6
| -4% | -$364 | ﹤0.01% | 4042 |
|
|
2017
Q1 | $9K | Sell |
138
-102
| -43% | -$6.65K | ﹤0.01% | 3845 |
|
|
2016
Q4 | $16K | Hold |
240
| – | – | ﹤0.01% | 3365 |
|
|
2016
Q3 | $16K | Buy |
240
+198
| +471% | +$13.2K | ﹤0.01% | 3298 |
|
|
2016
Q2 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 4249 |
|